The Effect of Topical Rho-kinase Inhibitors on Corneas of Patients With Fuchs Endothelial Corneal Dystrophy | MicrobiomeTrials← Back to trialsNCT06969586
The Effect of Topical Rho-kinase Inhibitors on Corneas of Patients With Fuchs Endothelial Corneal Dystrophy
ENROLLING_BY_INVITATIONOBSERVATIONAL
Trial Details
Start: 2025-04-01Est. Completion: 2026-12-01
Enrollment target: 50 participants Locations- University Hospital Dubrava, Zagreb, Croatia, Croatia
Other microbiome trials you might be interested in
Fuchs Endothelial Corneal Dystrophy
This protocol will investigate whether topical application of N-acetyl cysteine (NAC) eye drops decreases oxidative stre…
Boston, United StatesEst. completion Apr 29, 2027
CataractFuchs Endothelial Corneal Dystrophy
Study Overview
This study aims to evaluate the visual outcomes, quality of vision, and patient satisfaction after recei…
Leuven, BelgiumEst. completion Sep 2028